These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 5380093)

  • 1. [Familial pathology of diabetic retinopathy].
    Fischer F
    Dtsch Z Verdau Stoffwechselkr; 1969; 22():97-100. PubMed ID: 5380093
    [No Abstract]   [Full Text] [Related]  

  • 2. [Modern trends in diabetic retinopathy].
    Kojima M
    Ganka; 1966 Mar; 8(3):192-8. PubMed ID: 6006864
    [No Abstract]   [Full Text] [Related]  

  • 3. An igf-I gene polymorphism modifies the risk of diabetic retinopathy.
    Rietveld I; Ikram MK; Vingerling JR; Hofman A; Pols HA; Lamberts SW; de Jong PT; van Duijn CM; Janssen JA
    Diabetes; 2006 Aug; 55(8):2387-91. PubMed ID: 16873705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism of the manganese superoxide dismutase gene but not of vascular endothelial growth factor gene is a risk factor for diabetic retinopathy.
    Kangas-Kontio T; Vavuli S; Kakko SJ; Penna J; Savolainen ER; Savolainen MJ; Liinamaa MJ
    Br J Ophthalmol; 2009 Oct; 93(10):1401-6. PubMed ID: 19628492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MTHFR gene polymorphism is susceptible to diabetic retinopathy but not to diabetic nephropathy in Japanese type 2 diabetic patients.
    Maeda M; Yamamoto I; Fukuda M; Motomura T; Nishida M; Nonen S; Fujio Y; Kasayama S; Azuma J
    J Diabetes Complications; 2008; 22(2):119-25. PubMed ID: 18280442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The - 429 T/C and - 374 T/A gene polymorphisms of the receptor of advanced glycation end products gene are not risk factors for diabetic retinopathy in Caucasians with type 2 diabetes.
    Globocnik Petrovic M; Steblovnik K; Peterlin B; Petrovic D
    Klin Monbl Augenheilkd; 2003 Dec; 220(12):873-6. PubMed ID: 14704946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of the plasminogen activator inhibitor-1 gene in type 1 and type 2 diabetes, and in patients with diabetic retinopathy.
    Mansfield MW; Stickland MH; Carter AM; Grant PJ
    Thromb Haemost; 1994 Jun; 71(6):731-6. PubMed ID: 7974340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proliferating diabetic retinopathy and diabetic nephropathy].
    Fischer F
    Wien Med Wochenschr; 1969 Apr; 119(15):285-7. PubMed ID: 5769604
    [No Abstract]   [Full Text] [Related]  

  • 9. [A "pre-stage" of proliferant diabetic retinopathy].
    Fischer F
    Klin Monbl Augenheilkd; 1968; 152(4):538-42. PubMed ID: 5686089
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of lipid thrombi in the pathogenesis of diabetic retinopathy.
    Chester EM; Banker BQ
    Arch Intern Med; 1967 Oct; 120(4):397-407. PubMed ID: 6058095
    [No Abstract]   [Full Text] [Related]  

  • 11. [Quantification of diabetic retinopathy; yes or no?].
    Bernsmeier H; Romberg G; Friedburg D
    Fortschr Ophthalmol; 1983; 80(4):342-4. PubMed ID: 6629266
    [No Abstract]   [Full Text] [Related]  

  • 12. Relation between retinal thickening and clinically visible fundus pathologies in mild nonproliferative diabetic retinopathy.
    Nishiwaki H; Shahidi M; Vitale S; Alexander J; Asran S; Mori M; Blair NP; Zeimer R
    Ophthalmic Surg Lasers; 2002; 33(2):127-34. PubMed ID: 11942544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fluorescein angiographic manifestations of diabetic retinopathy].
    Wang LT
    Zhonghua Yan Ke Za Zhi; 1983 Sep; 19(5):280-3. PubMed ID: 6418485
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on ACE gene insertion/deletion polymorphism, serum ACE activity, and diabetic retinopathy in type II diabetic patients].
    Liao L; Lei M; Chen H; Han X; Fan C
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(1):33-6. PubMed ID: 11938734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic complications and the genetics of signal transduction. A study of retinopathy in NIDDM.
    Lucarini N; Bottini N; Antonacci E; Borgiani P; Faggioni G; Gloria-Bottini F
    Dis Markers; 1997 Nov; 13(3):169-76. PubMed ID: 9405929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between polymorphisms 804C/A and 252A/G of lymphotoxin-alpha gene and -308G/A of tumor necrosis factor alpha gene and diabetic retinopathy in Japanese patients with type 2 diabetes mellitus.
    Yoshioka K; Yoshida T; Takakura Y; Umekawa T; Kogure A; Toda H; Yoshikawa T
    Metabolism; 2006 Oct; 55(10):1406-10. PubMed ID: 16979413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The relationship of methylenetetrahydrofolate reductase gene polymorphism and plasma homocysteine levels in type 2 diabetes mellitus patients with diabetic retinopathy].
    Sun J; Xu Y; Zhu Y; Lu H; Deng H; Fan Y; Sun S; Zhang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):131-4. PubMed ID: 12673582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The relationship of angiotensin I-converting enzyme gene polymorphism with diabetic retinopathy and diabetes myocardial infarction].
    Wu SS; Guo QM; Liu GL; Zhang J; Zhao CF; Ning SC; Zhao LN; Yu F; Yi HL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Jun; 21(3):283-5. PubMed ID: 15192839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of diabetic retinopathy lesions of the posterior pole and retinal periphery in 200 diabetics].
    Devlamynck S; Bondu G
    Bull Soc Ophtalmol Fr; 1982 Dec; 82(12):1593-6. PubMed ID: 6191882
    [No Abstract]   [Full Text] [Related]  

  • 20. VEGF polymorphisms are associated with severity of diabetic retinopathy.
    Churchill AJ; Carter JG; Ramsden C; Turner SJ; Yeung A; Brenchley PE; Ray DW
    Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3611-6. PubMed ID: 18441306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.